Paragon Banking Group PLC logo

Paragon Banking Group PLC (PAG)

Market Closed
12 Jun, 15:30
LSE LSE
759. 50
GBX
+17.5
+2.3585%
GBX
- Market Cap
- P/E Ratio
- Div Yield
306,331 Volume
- Eps
742 GBX
Previous Close
Add Transaction
Day Range
742.54 764
Year Range
681.5 981
Want to track PAG and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

PAG closed today higher at 759.5 GBX, an increase of 2.3585% from yesterday's close, completing a monthly increase of 1.4019% or 10.5 GBX. Over the past 12 months, PAG stock lost -13.2%.
PAG pays dividends to its shareholders, with the most recent payment made on Mar 06, 2026. The next announced payment will be in In 1 month on Jul 24, 2026 for a total of 15.1 GBX.
The last earnings report, released on Jun 02, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Paragon Banking Group PLC has completed 3 stock splits, with the recent split occurring on Jan 29, 2008.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XSTU (EUR).

PAG Chart

Paragon Banking Group PLC (PAG) FAQ

What is the stock price today?

The current price is 759.50 GBX.

On which exchange is it traded?

Paragon Banking Group PLC is listed on LSE.

What is its stock symbol?

The ticker symbol is PAG.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Paragon Banking Group PLC ever had a stock split?

Paragon Banking Group PLC had 3 splits and the recent split was on Jan 29, 2008.

Paragon Banking Group PLC Profile

Mortgage Real Estate Investment Trusts (REITs) Industry
Financials Sector
Kai Sun CEO
LSE Exchange
G6376N154 CUSIP
AU Country
6 Employees
5 Feb 2026 Last Dividend
29 Jan 2008 Last Split
- IPO Date

Overview

TrivarX Limited, initially known as Medibio Limited, is a pioneering health technology company focused on the advancement of mental health care through innovative detection and screening technologies. Founded in 1987 and headquartered in Mount Lawley, Australia, the company has expanded its operations to both Australia and the United States. With a strong commitment to improving mental well-being, TrivarX Limited serves a dual market comprising both businesses seeking corporate health solutions and healthcare providers looking for effective tools in mental health diagnosis and management. In October 2023, the company underwent a significant rebranding to TrivarX Limited, marking a new chapter in its mission to enhance mental health care globally.

Products and Services

TrivarX Limited offers a range of innovative solutions designed to support mental well-being in various settings:

  • Corporate Health Product: This service is tailored for businesses aiming to safeguard and enhance the mental health of their employees. By integrating TrivarX's cutting-edge technologies, companies can access effective tools for early detection and ongoing screening of mental health conditions, thereby fostering a healthier workplace environment.
  • Healthcare Provider Products: Developed with healthcare professionals in mind, these products facilitate the accurate assessment and management of mental health conditions. TrivarX Limited leverages advanced technology to provide reliable, evidence-based solutions that aid in the diagnostic process, offering a valuable resource for practitioners in the mental health field.

Contact Information

Address: 647 Beaufort Street
Phone: 61 8 6189 1155